Addus HomeCare’s (ADUS) Market Outperform Rating Reiterated at JMP Securities

JMP Securities reiterated their market outperform rating on shares of Addus HomeCare (NASDAQ:ADUS) in a report published on Tuesday morning,Benzinga reports. The brokerage currently has a $150.00 target price on the stock.

Several other research analysts also recently commented on ADUS. Macquarie reissued an “outperform” rating and set a $129.00 price objective on shares of Addus HomeCare in a report on Thursday, February 27th. Oppenheimer lifted their price objective on Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. StockNews.com downgraded Addus HomeCare from a “buy” rating to a “hold” rating in a research report on Wednesday, February 26th. Finally, Stephens restated an “overweight” rating and issued a $142.00 price target on shares of Addus HomeCare in a research report on Wednesday, March 12th. One equities research analyst has rated the stock with a hold rating, seven have issued a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, Addus HomeCare currently has an average rating of “Buy” and an average price target of $139.00.

Addus HomeCare Stock Up 0.7 %

Shares of NASDAQ:ADUS opened at $99.54 on Tuesday. The firm’s 50 day moving average price is $98.20 and its 200-day moving average price is $116.35. The stock has a market capitalization of $1.81 billion, a PE ratio of 22.78, a price-to-earnings-growth ratio of 1.41 and a beta of 0.93. Addus HomeCare has a twelve month low of $88.96 and a twelve month high of $136.72.

Addus HomeCare (NASDAQ:ADUS) last released its earnings results on Monday, February 24th. The company reported $1.26 EPS for the quarter, missing analysts’ consensus estimates of $1.35 by ($0.09). The firm had revenue of $297.14 million for the quarter, compared to the consensus estimate of $291.04 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. Analysts expect that Addus HomeCare will post 4.59 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Addus HomeCare

A number of institutional investors have recently modified their holdings of the stock. Natixis increased its stake in shares of Addus HomeCare by 111.9% during the fourth quarter. Natixis now owns 250 shares of the company’s stock valued at $31,000 after buying an additional 132 shares during the period. Smartleaf Asset Management LLC lifted its position in Addus HomeCare by 324.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 280 shares of the company’s stock valued at $35,000 after acquiring an additional 214 shares during the last quarter. Parkside Financial Bank & Trust boosted its position in shares of Addus HomeCare by 38.6% in the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company’s stock worth $67,000 after purchasing an additional 148 shares in the last quarter. Meeder Asset Management Inc. purchased a new position in Addus HomeCare during the 4th quarter worth $77,000. Finally, Harvest Fund Management Co. Ltd acquired a new position in shares of Addus HomeCare during the fourth quarter valued at about $86,000. 95.35% of the stock is owned by hedge funds and other institutional investors.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.